Skip to main content
Top
Published in: Autoimmunity Highlights 1/2020

01-12-2020 | Systemic Lupus Erythematosus | Case Report

Recurrent angioedema, Guillain-Barré, and myelitis in a girl with systemic lupus erythematosus and CD59 deficiency syndrome

Authors: Vadood Javadi Parvaneh, Leila Ghasemi, Khosro Rahmani, Reza Shiari, Mahbobeh Mesdaghi, Zahra Chavoshzadeh, Seyed Hassan Tonekaboni

Published in: Autoimmunity Highlights | Issue 1/2020

Login to get access

Abstract

Background

CD59 deficiency is a congenital mutation disorder in complement pathway which can present with various manifestations.

Case presentation

Herein, we presented an adolescent 16-years-old girl with recurrent attacks of Guillain-Barre in early childhood and then recurrent attacks of angioedema, paresthesia, and myelitis. Finally, she presented with quadriplegia, malar rash, proteinuria, lymphopenia, and high titer of antinuclear antibody. So, the patient developed systemic lupus erythematosus. Furthermore, we performed whole exome sequencing which revealed homozygote mutations in CD59 for the patient and heterozygote one for her parents. CD flow cytometry showed less than 1 percent expression of CD59 on the surface of the patient’s peripheral blood cells confirming the disorder. So, she had CD59 deficiency. The patient’s episodes were managed with plasma exchanges, corticosteroids, Cyclophosphamide, and Mycophenolate Mofetil which induced and maintained remission.

Conclusion

CD59 deficiency can be presented with various clinical features such as neurologic, hematologic, dermatologic, and rheumatologic problems including systemic lupus erythematosus.
Literature
1.
go back to reference Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann N Y Acad Sci. 2009;1173(1):108–23.CrossRef Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann N Y Acad Sci. 2009;1173(1):108–23.CrossRef
2.
go back to reference Winkelstein J, Gewurz AT, Lint TF, et al. The complement system. In: Adkinson NF, Yunginger JW, Busse WW, et al., editors. Middleton’s allergy principles & practice, vol. 1. Philadelphia: Mosby, Inc.; 2003. p. 66–85. Winkelstein J, Gewurz AT, Lint TF, et al. The complement system. In: Adkinson NF, Yunginger JW, Busse WW, et al., editors. Middleton’s allergy principles & practice, vol. 1. Philadelphia: Mosby, Inc.; 2003. p. 66–85.
3.
go back to reference Unsworth DJ. Complement deficiency and disease. J Clin Pathol. 2008;61:1013–107.CrossRef Unsworth DJ. Complement deficiency and disease. J Clin Pathol. 2008;61:1013–107.CrossRef
4.
go back to reference Nevo Y, Ben-Zeev B, Tabib A, et al. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood. 2013;121(1):129–35.CrossRef Nevo Y, Ben-Zeev B, Tabib A, et al. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood. 2013;121(1):129–35.CrossRef
5.
go back to reference Ardicli D, Taskiran EZ, Kosukcu C, et al. Neonatal-onset recurrent Guillain-Barré syndrome-like disease: clues for inherited CD59 deficiency. Neuropediatrics. 2017;48(06):477–81.CrossRef Ardicli D, Taskiran EZ, Kosukcu C, et al. Neonatal-onset recurrent Guillain-Barré syndrome-like disease: clues for inherited CD59 deficiency. Neuropediatrics. 2017;48(06):477–81.CrossRef
6.
go back to reference Haliloglu G, Maluenda J, Sayinbatur B, et al. Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency. Neurology. 2015;84(12):1220–4.CrossRef Haliloglu G, Maluenda J, Sayinbatur B, et al. Early-onset chronic axonal neuropathy, strokes, and hemolysis: inherited CD59 deficiency. Neurology. 2015;84(12):1220–4.CrossRef
7.
go back to reference Tabib A, Karbian N, Mevorach D. Demyelination, strokes, and eculizumab: lessons from the congenital CD59 gene mutations. Mol Immunol. 2017;1(89):69–72.CrossRef Tabib A, Karbian N, Mevorach D. Demyelination, strokes, and eculizumab: lessons from the congenital CD59 gene mutations. Mol Immunol. 2017;1(89):69–72.CrossRef
8.
go back to reference Klemann C, Kirschner J, Ammann S, Urbach H, Moske-Eick O, Zieger B, et al. CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels. Eur J Paediat Neurol. 2018;22(5):870–7.CrossRef Klemann C, Kirschner J, Ammann S, Urbach H, Moske-Eick O, Zieger B, et al. CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels. Eur J Paediat Neurol. 2018;22(5):870–7.CrossRef
9.
go back to reference Höchsmann B, Dohna-Schwake C, Kyrieleis HA, et al. Targeted therapy with Eculizumab for inherited CD59 deficiency. N Engl J Med. 2014;370(1):90–2.CrossRef Höchsmann B, Dohna-Schwake C, Kyrieleis HA, et al. Targeted therapy with Eculizumab for inherited CD59 deficiency. N Engl J Med. 2014;370(1):90–2.CrossRef
Metadata
Title
Recurrent angioedema, Guillain-Barré, and myelitis in a girl with systemic lupus erythematosus and CD59 deficiency syndrome
Authors
Vadood Javadi Parvaneh
Leila Ghasemi
Khosro Rahmani
Reza Shiari
Mahbobeh Mesdaghi
Zahra Chavoshzadeh
Seyed Hassan Tonekaboni
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Autoimmunity Highlights / Issue 1/2020
Print ISSN: 2038-0305
Electronic ISSN: 2038-3274
DOI
https://doi.org/10.1186/s13317-020-00132-2

Other articles of this Issue 1/2020

Autoimmunity Highlights 1/2020 Go to the issue